| ²é¿´: 2304 | »Ø¸´: 5 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
swordzhou½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
×¢Éä¼ÁлᣨPDA)ÕýÔÚÐÞ¶©ÎÞ¾úÒ©Æ·µÄ¼¼Êõ±¨¸æ ÒÑÓÐ5È˲ÎÓë
|
||
|
PDA Revises Technical Report on Sterilized Products May 22, 2012 By: Susan Haigney The Parenteral Drug Association has released a revision of Technical Report 30 (TR 30), Parametric Release of Pharmaceuticals and Medical Device Products TerminallySterilized by Moist Heat. The revised report, originally published in 1999, provides current best practices of the sterile product release method and emphasizes the use of science-based approaches when developing a parametric release program for ¡°pharmaceutical and medical device products terminally sterilized by moist heat.¡± The original TR 30 outlined a sterility assurance release program that utilized effective control, monitoring, and documentation of a validated sterile product manufacturing process dependent on achievement of critical operational parameters instead of end product sterility testing. A group of international industry scientists, microbiologists, and engineers participated in the revision of TR 30. PDA members can access TR 30 for free until June 15, 2012. |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
ÈçºÎ¸ßЧµÄ²âÁ¿ÏÙ²¡¶¾µÄÁ£¾¶ºÍµçλ
ÒѾÓÐ0È˻ظ´
¹ØÓÚSCIÔÓÖ¾·¢±í¹ÒÃû
ÒѾÓÐ32È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ114È˻ظ´
26ÔÚÖ°É격¡ªÉúÎïÓëÒ½Ò©¡ª¿¹Ìå/ADCÒ©Îï·½Ïò£¬½Õ㻦£¬ÓÐÏîÄ¿£¬¿É´ø×Ê¡£
ÒѾÓÐ1È˻ظ´
288·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸ËÕÖÝ´óѧ ÉúÎï¼¼ÊõÓ빤³Ì£¨086001£© ³õÊÔ323·Ö£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÈýÄêʵÑéÊÒ¹¤×÷¾Àú£¬Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ΢ÉúÎ×Ü·Ö288Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
070700Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
Çóµ÷¼Á×Ü·Ö327
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
°ïæ·ÖÎöÏÂASPEN PLUS 11.1ÖеÄÕâ¸ö´íÎ󱨸æ
ÒѾÓÐ10È˻ظ´
¹ØÓÚ×¢Éä¼ÁÎÞ¾ú¼ì²éºÍÑé֤ʱ³åÏ´Á¿ºÍ³åÏ´´ÎÊýÏà¹ØÎÊÌâ¡£
ÒѾÓÐ18È˻ظ´
ÃÀ¹ú×¢Éä¼Áлá(PDA)µÚ44ºÅ¼¼Êõ±¨¸æ¡ª¡ªÎÞ¾úÖÊÁ¿·çÏÕ¹ÜÀí½éÉÜ2011.ppt
ÒѾÓÐ41È˻ظ´
¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾Ö·¢²¼¡¶2010ÄêÒ©Æ·×¢²áÉóÅúÄê¶È±¨¸æ¡·
ÒѾÓÐ13È˻ظ´
2010°æGMPʵʩָÄÏ£¨ÎÞ¾úÒ©Æ·£©--SFDAÕýʽ°æ-2011Äê8Ô³ö°æ
ÒѾÓÐ42È˻ظ´
¶àÕ³ÀàÑ¿æß¸Ë¾ú·¢½ÍÒºÏñºÜÕ³³í£¬ÈçºÎ»ñµÃÆäÎÞ¾úÂËÒº£¿
ÒѾÓÐ17È˻ظ´
0.038mgÒ©Æ·ÈçºÎ³ÆÈ¡
ÒѾÓÐ25È˻ظ´
¡¾ÇóÖú¡¿Ò©Æ·¡°Veenat¡±Ïà¹ØÐÅÏ¢¼ìË÷
ÒѾÓÐ3È˻ظ´

Aliwry
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
×ÊÉîαÎÄÇà
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 0.317
- ½ð±Ò: 9594.6
- É¢½ð: 3861
- ºì»¨: 172
- ɳ·¢: 2
- Ìû×Ó: 2622
- ÔÚÏß: 492.9Сʱ
- ³æºÅ: 1741481
- ×¢²á: 2012-04-07
- ÐÔ±ð: MM
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
- ¹ÜϽ: Ö°³¡ÈËÉú
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
69 Bioburden and Biofilm Management in Pharmaceutical Manufacturing Operations Ò©Æ·Éú²úÖÆÔì¹ý³ÌÖеÄÉúÎ︺ºÉºÍÉúÎïĤµÄ¹ÜÀí 2015 70 Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities ÎÞ¾úÉú²úÉèÊ©µÄÇå½àÓëÏû¶¾³ÌÐò»ù´¡ 2015 71 Emerging Methods for Virus Detection ²¡¶¾¼ì²âµÄÏÖÐкÍÐÂÐË·½·¨ 2015 |

6Â¥2015-12-03 10:38:13














»Ø¸´´ËÂ¥
³¯³¯ÓÚ